Design Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $2.5M | $36.5M | $2.4M |
| FY2021 | $8.4M | $390.6M | $298.6M |
| FY2022 | $13.8M | $341.1M | $26.5M |
| FY2023 | $12.0M | $289.6M | $21.2M |
| FY2024 | $10.0M | $252.1M | $22.6M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $2.5M | $36.5M | $2.4M |
| FY2021 | $8.4M | $390.6M | $298.6M |
| FY2022 | $13.8M | $341.1M | $26.5M |
| FY2023 | $12.0M | $289.6M | $21.2M |
| FY2024 | $10.0M | $252.1M | $22.6M |